ARUBA: "Medical Management With or Without Interventional Therapy for Unruptured Brain Arteriovenous Malformations"
The clinical benefit of preventive eradication of unruptured brain arteriovenous malformations remains uncertain.
A randomised trial of unruptured Brain Arteriovenous malformations (ARUBA) aims to compare the risk of death and symptomatic stroke in patients with an unruptured brain arteriovenous malformation who are allocated to either medical management alone or medical management with interventional therapy.
Read More

Mount Sinai Implements Own the Bone® Program for Fragility Fracture Patients
Jul 08, 2025 View All Press Releases
Mount Sinai Establishes Steven S. Elbaum Family Center for Caregiving
May 20, 2025 View All Press Releases
Mount Sinai Surgeons Perform First Heart-Liver-Kidney Transplants in New York State
May 20, 2025 View All Press Releases